Journal profile · RESPIRATORY SYSTEM
Pneumonia
ISSN 2200-6133 · BMC · United Kingdom
Pneumonia: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.8 (journal website); fully open access; APC about USD 2,590; median 132 days to acceptance (55 articles, last 24 months); 35 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Pneumonia is published by BMC and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pneumonia and Respiratory Infections, Respiratory viral infections research and Nosocomial Infections in ICU, together about 56.3% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Pneumonia is the only journal to focus exclusively on pneumonia. Publishing original research, case reports, reviews, commentaries and correspondence, Pneumonia provides an international forum for the exchange of knowledge by scientists and clinicians involved in studying the etiology and pathogenesis of pneumonia, as well as its diagnosis, epidemiology, treatment and prevention. The journal's scope extends to research on lung infections and diagnosis, inflammation and immunity, microbial pathogenesis and viral-bacterial interactions. Cutting-edge research, insightful reviews and dedication to the community make Pneumonia an essential resource for clinicians, researchers, respirologists and allied professionals involved with infectious diseasea.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Giovanni SotgiuPublisher website
Editorial board by country: none in mainland China; most named United States 14, Australia 11, United Kingdom 10, Italy 6, Spain 5 (76 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pneumonia and Respiratory InfectionsMedicine31.2%
- Respiratory viral infections researchMedicine18.2%
- Nosocomial Infections in ICUMedicine6.9%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine4.8%
- Bacterial Infections and VaccinesImmunology and Microbiology4%
- Antibiotic Use and ResistanceImmunology and Microbiology3.8%
- Tuberculosis Research and EpidemiologyMedicine3.3%
- COVID-19 Clinical Research StudiesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.5Publisher website ·
- h-index
- 34OpenAlex ·
- i10-index
- 97OpenAlex ·
- 2-year mean citedness
- 3.45OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 33LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 296,200Publisher website ·
Articles by year OpenAlex count · 285 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 24 |
| 2025 | 35 | 35 | 96 |
| 2024 | 31 | 31 | 180 |
| 2023 | 18 | 18 | 236 |
| 2022 | 10 | 10 | 415 |
| 2021 | 14 | 14 | 631 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
132 daysMedian, submission to acceptance · P25–P75 94 days – 184 days
- Acceptance to online
- median 64 days (55 articles)
- Submission to online
- median 196 days
- Sample
- 55 articles with submission and acceptance dates (69 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to first decision
- 10 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,890 / USD 2,590 / EUR 2,190 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,690 / EUR 2,290 / GBP 1,990 | — | — | |
| LetPub | GBP 1,890 / USD 2,590 / EUR 2,190 | Yes | — | |
| Publisher website | GBP 1,890 / USD 2,590 / EUR 219 / EUR 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted7
- brief reportsResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- case reportsResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- commentResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- correspondenceResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- editorialResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- researchResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
- reviewsResearch Reviews Brief reports Case reports Comment Correspondence EditorialLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Pneumonia articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Commercia…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMC
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2200-6133
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pneumonia
What CAS zone is Pneumonia in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pneumonia is in Zone 3 of Medicine, and in Zone 3 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pneumonia?
The journal's website gives an impact factor of 3.8 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 34.
How long does peer review take at Pneumonia?
Based on the dates recorded on 55 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 132 days (interquartile range 94–184 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pneumonia based?
Of the 76 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (14), Australia (11) and United Kingdom (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Pneumonia?
According to LetPub and DOAJ records, Pneumonia is indexed in ESCI and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is Pneumonia open access, and what is the APC?
Pneumonia is a fully open-access journal. APC about USD 2,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .